Melanoma in horses: Current perspectives

Equine Veterinary Education

Volumn 25, Issue 3, 2013, Pages 144-151

  Moore, J S ^a   Shaw, C ^b   Shaw, E ^b   Buechner Maxwell, V ^a   Scarratt, W K ^a   Crisman, M ^a   Furr, M ^c   Robertson, J ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

^c MARION DUPONT SCOTT EQUINE MEDICAL CENTER   (United States)

Author keywords

Dermal melanomatosis; Equine melanoma; Equine neoplasia; Horse; Melanocytic nevus; Visceral melanoma

Indexed keywords

EQUIDAE;

EID: 84873257367     PISSN: 09577734     EISSN: 20423292     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2011.00368.x     Document Type: Article

References (49)

1. Baptiste, K., Moll, H.D. and Robertson, J.L. (1996) Three cases of tumors associated with the equine guttural pouch. Can. Vet. J. 37, 499-501.
2. Bowers, J.R., Huntington, P.J. and Slocombe, R.F. (1994) Efficacy of cimetidine for therapy of skin tumours of horses- 10 cases. Aust. Equine Vet. 12, 30-32.
3. Caston, S.S. and Fales-Williams, A. (2010) Primary malignant melanoma in the oesophagus of a foal. Equine Vet. Educ. 22, 387-390.
4. Covington, A.L., Magdesian, K.G., Madigan, J.E., Maleski, K., Gray, L.C., Smith, P.A. and Wisner, E.R. (2004) Recurrent esophageal obstruction and dysphagia due to a brainstem melanoma in a horse. J. Vet. Intern. Med. 18, 245-247.
5. Cox, J.H., DeBowes, R.M. and Leipold, H.W. (1989) Congenital malignant melanoma in two foals. J. Am. Vet. Med. Ass. 194, 945-947.
6. Dick, W. (1832) Letter: Melanosis in men and horses. Lancet 1, 192; as cited by Levene, A. (1971) Equine melanotic disease. Tumori57, 133-168.
7. Ebbs, S.R., Roberts, J.V. and Baum, M. (1987) Alternative mechanism of action of antiestrogens in breast cancer. Lancet 2, 621.
8. Eisenthal, A., Monselise, J., Zinger, R. and Adler, A. (1986) The effect of cimetidine on PBL from healthy donors and melanoma patients: Augmentation of T cell responses to TCGF* mitogens and alloantigens and of TCGF production. Cancer Immunol. Immunother. 21, 141-147.
9. Finocchiaro, L.M.E., Riveros, M.D. and Glikin, G.C. (2009) Cytokine-enhanced vaccine and suicide gene therapy as adjuvant treatments of metastatic melanoma in a horse. Vet. Rec. 164, 278-279.
10. Fleury, C., Berard, F., Balme, B. and Thomas, L. (2000) The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): Clinical-pathological characterization. Pigment Cell Res. 13, 39-46.
11. Goetz, T.E., Ogilvie, G.K., Keegan, K.G. and Johnson, P.J. (1990) Cimetidine for treatment of melanoma in three horses. J. Am. Vet. Med. Ass. 196, 449-452.
12. Hamilton, D.P. and Byerly, C.S. (1974) Congenital malignant melanoma in a foal. J. Am. Vet. Med. Ass. 164, 1040-1041.
13. Heinzerling, L.M., Feige, K., Rieder, S., Akens, M.K., Dummer, R., Stranzinger, G. and Moelling, K. (2001) Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J. Mol. Med. 78, 692-702.
14. Hewes, C.A. and Sullins, K.E. (2006) Use of cis-platinum containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004). J. Am. Vet. Med. Ass. 229, 1617-1622.
15. Jaeger, A. (1909) Die melanosarkomatose der Schimmelpferde [Melanosarcomatosis of grey horses]. Virchows Arch. Pathol. Anat. Physiol. 198, 1-61.
16. Jeglum, K.A. (1997) Melanomas. In: Current Therapy in Equine Medicine, 4th edn., Ed: N. Robinson, W.B. Saunders, Philadelphia. pp 399-400.
17. Kirker-Head, C.A., Loeffler, D. and Held, J.P. (1985) Pelvic limb lameness due to malignant melanoma in a horse. J. Am. Vet. Med. Ass. 186, 1215-1217.
18. Laus, F., Cerquetella, M., Paggi, E., Ippedico, G., Argentieri, M., Castellano, G., Spaterna, A. and Tesei, B. (2010) Evaluation of cimetidine as a therapy for dermal melanomatosis in grey horse. Israel J. Vet. Med. 65, 48-52.
19. Law, J. (1916) Diseases of the skin. In: Special Report on Diseases of the Horse, Eds: L. Pearson, Ch.B. Michener, J. Law, W.H. Harbaugh, M.R. Trumbower, A. Liautard, A.A. Holcombe, R.S. Huidekoper, J. Mohler, A. Eichhorn, M.C. Hall and J.W. Adams, Government Printing Office, Washington, DC. pp 458-483.
20. Leblanc, P., Cadeac, C. and Carougeau, C. (1902) Pathologie Chirurgicale Generale, Balliere, Paris. pp 353-354.
21. Levene, A. (1979) Disseminated dermal melanocytosis terminating in melanoma. Br. J. Dermatol. 101, 197-205.
22. Levene, A. (1980) On the history and comparative pathology of the Blue Naevus. Ann. R. Coll. Surg. Engl. 62, 327-334.
23. MacGillivray, K., Sweeney, R. and Del Piero, F. (2002) Metastatic melanoma in horses. J. Vet. Intern. Med. 16, 452-456.
24. Mäenpää, J., Dooley, T., Wurz, G., VandeBerg, J., Robinson, E., Emshoff, V., Sipila, P., Wiebe, V., Day, C. and DeGregorio, M. (1993) Topical toremifene: A new approach for cutaneous melanoma? Cancer Chemother. Pharmacol. 32, 392-395.
25. McFadyean, J. (1933) Equine melanomatosis. J. Comp. Pathol. Ther. 46, 186-204.
26. Müller, J., Feige, K., Wunderlin, P., Hödl, A., Meli, M.L., Seltenhammer, M., Grest, P., Nicolson, L., Schelling, C. and Heinzerling, L.M. (2011) Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses. J. Immunother. 34, 58-64.
27. Murray, M.J., Cavey, D.M., Feldman, B.F., Trostle, S.S. and White, N.A. (1997) Signs of sympathetic denervation associated with thoracic melanoma in a horse. J. Vet. Intern. Med. 11, 199-203.
28. Patterson-Kane, J.C., Sanchez, L.C., Uhl, E.W. and Edens, L.M. (2001) Disseminated metastatic intramedullary melanoma in an aged grey horse. J. Comp. Pathol. 125, 204-207.
29. Pielberg, G., Golovko, A., Sundstrom, E., Curik, I., Lennartsson, J., Seltenhammer, M.H., Druml, T., Binns, M., Fitzsimmons, C., Lindgren, G., Sandberg, K., Baumung, R., Vetterlein, M., Stromberg, S., Grabherr, M., Wade, C., Lindblad-Toh, K., Ponten, F., Heldin, C., Solkner, J. and Andersson, L. (2008) A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat. Genet. 40, 1004-1009.
30. Pulley, L.T. and Stannard, A.A. (1990) Tumors of the skin and soft tissues. In: Tumors in Domestic Animals, 3rd edn., Ed: J.E. Moulton, University of California Press, Berkley. pp 75-82.
31. Robertson, J. (1996) Melanoma. In: Equine Pathology, Eds: J. Rooney and J. Robertson, Iowa State University Press, Ames. pp 304-305.
32. Rodriguez, F., Forga, J., Herraez, P., Andrade, M. and Fernandez, M. (1998) Metastatic melanoma causing spinal cord compression in a horse. Vet. Rec. 142, 248-249.
33. Rodriguez, M., Garcia-Barona, J., Pera, L., Castano, M. and Rodriguez, A. (1997) A grey horse melanotic condition: a pigmentary disorder. J. Equine Vet. Sci. 17, 677-681.
34. Rowe, E. and Sullins, K. (2004) Excision for treatment of dermal melanomatosis in horses: 11 cases (1994-2000). J. Am. Vet. Med. Ass. 225, 94-96.
35. Runnells, R.A. and Benbrook, E.A. (1941) Malignant melanoma of horses and mules. Am. J. Vet. Res. 2, 340-344.
36. Rywlin, A.M. (1989) Malignant melanoma in light of the multistep theory of neoplasia. Am. J. Dermatopathol. 11, 387-389.
37. Sahasrabudhe, D.M., McCune, C.S., O'Donnell, R.W. and Henshaw, E.C. (1987) Inhibition of suppressor T-Lymphocytes (Ts) by cimetidine. J. Immunol. 138, 2760-2763.
38. Schott, H.C., Major, M.D., Grant, B.D. and Bayly, W.M. (1990) Melanoma as a cause of spinal cord compression in two horses. J. Am. Vet. Med. Ass. 196, 1820-1822.
39. Scott, D.W. (1988) Neoplastic diseases. In: Large Animal Dermatology, W.B. Saunders, Philadelphia. pp 448-452.
40. Seltenhammer, M.H., Heere-Ress, E., Brandt, S., Druml, T., Jansen, B., Pehamberger, H. and Niebauer, G.W. (2004) Comparative histopathology of grey-horse-melanoma and human malignant melanoma. Pigment Cell Res. 17, 674-681.
41. Seltenhammer, M.H., Simhofer, H., Scherzer, S., Zechner, P., Curik, I., Sölkner, J, Brandt, S.M., Jansen, B., Pehamberger, H. and Eisenmenger, E. (2003) Equine melanoma in a population of 296 grey Lipizzaner horses. Equine Vet. J. 35, 153-157.
42. Soe, L., Wurz, G.T., Maenpaa, J.U., Hubbard, G.B., Cadman, T.B., Wiebe, V.J., Theon, A.P. and Degregorio, M.W. (1997) Tissue distribution of transdermal toremifene. Cancer Chemother. Pharmacol. 39, 513-520.
43. Tarrant, J., Stokol, T., Bartol, J., Wakshlag, J. and Blue, J. (2001) Diagnosis of malignant melanoma in a horse from cytology of body cavity fluid and blood. Equine Vet. J. 33, 531-535.
44. Theon, A.P., Magdesian, K.G. and Snyder, J.R. (2007) Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004). J. Am. Vet. Med. Ass. 230, 1506-1513.
45. Traver, D.S., Moore, J.N., Thornburg, L.P., Johnson, J.H. and Coffman, J.R. (1977) Epidural melanoma causing posterior paresis in a horse. J. Am. Vet. Med. Ass. 179, 1400-1140.
46. Valavaara, R., Pyrhonen, S., Heikkinen, M., Rissanen, P., Blanco, G., Tholix, E., Nordman, E., Taskinen, P., Holsti, L. and Hajba, A. (1988) Toremifene, a new antiestrogenic compound for treatment of advanced breast cancer. Phase II study. Eur. J. Cancer 24, 785-790.
47. Valentine, B. (1995) Equine melanocytic tumors: A retrospective study of 53 horses. J. Vet. Intern. Med. 9, 291-297.
48. Warnick, L.D., Graham, M.E. and Valentine, B.A. (1995) Evaluation of cimetidine treatment for melanomas in seven horses. Equine Pract. 17, 16-22.
49. Whitehead, R.J., Taylor, D.J., Evanson, J.M., Hart, I.R. and Woolley, D.E. (1988) Demonstration of histamine H2 receptors on human melanoma cells. Biochem. Biophys. Res. Commun. 29, 518-523.